Our data show that hepatic FOXA3 improves diet-induced obesity and MASH in WT mice, but not in Tgr5−/− mice, suggesting that activation of TGR5 plays a key role in mediating the beneficial effects of FOXA3. Here, GPBAR1 is linked to obesity disorder.